Imperial College London

ProfessorHolgerAuner

Faculty of MedicineDepartment of Immunology and Inflammation

Visiting Professor
 
 
 
//

Contact

 

holger.auner04 Website

 
 
//

Assistant

 

Miss Mandy Sale +44 (0)20 3313 4017

 
//

Location

 

4N7ACommonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Mateos:2020:10.1182/blood-2020-138391,
author = {Mateos, M and Gavriatopoulou, M and Facon, T and Auner, HW and Leleu, X and Hajek, R and Dimopoulos, MA and Delimpasi, S and Simonova, M and Spicka, I and Pour, L and Kryachok, I and Pylypenko, H and Doronin, VA and Usenko, G and Benjamin, R and Dolai, TK and Sinha, DK and Venner, CP and Garg, M and Stevens, DA and Quach, H and Jagannath, S and Moreau, P and Levy, M and Badros, AZ and Anderson, LD and Bahlis, NJ and Cavo, M and Chai, Y and Arazy, M and Shah, J and Shacham, S and Kauffman, MG and Richardson, PG and Grosicki, S},
doi = {10.1182/blood-2020-138391},
publisher = {AMER SOC HEMATOLOGY},
title = {Effect of Prior Treatment with Proteasome Inhibitors on the Efficacy and Safety of Once-Weekly Selinexor, Bortezomib, and Dexamethasone in Comparison with Twice-Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Subgroup Analysis from the Boston Study},
url = {http://dx.doi.org/10.1182/blood-2020-138391},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Mateos,M
AU - Gavriatopoulou,M
AU - Facon,T
AU - Auner,HW
AU - Leleu,X
AU - Hajek,R
AU - Dimopoulos,MA
AU - Delimpasi,S
AU - Simonova,M
AU - Spicka,I
AU - Pour,L
AU - Kryachok,I
AU - Pylypenko,H
AU - Doronin,VA
AU - Usenko,G
AU - Benjamin,R
AU - Dolai,TK
AU - Sinha,DK
AU - Venner,CP
AU - Garg,M
AU - Stevens,DA
AU - Quach,H
AU - Jagannath,S
AU - Moreau,P
AU - Levy,M
AU - Badros,AZ
AU - Anderson,LD
AU - Bahlis,NJ
AU - Cavo,M
AU - Chai,Y
AU - Arazy,M
AU - Shah,J
AU - Shacham,S
AU - Kauffman,MG
AU - Richardson,PG
AU - Grosicki,S
DO - 10.1182/blood-2020-138391
PB - AMER SOC HEMATOLOGY
PY - 2020///
SN - 0006-4971
TI - Effect of Prior Treatment with Proteasome Inhibitors on the Efficacy and Safety of Once-Weekly Selinexor, Bortezomib, and Dexamethasone in Comparison with Twice-Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Subgroup Analysis from the Boston Study
UR - http://dx.doi.org/10.1182/blood-2020-138391
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000607547203050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -